Data Characteristics for this Category
Quality documents for siRNA nucleic acid drugs primarily include raw material inspection reports, intermediate control data, finished product release inspection reports, stability study data, batch production records, change control documents, deviation handling reports, and validation documents. These documents typically originate from analytical equipment such as high-throughput sequencers, mass spectrometers, and high-performance liquid chromatographs, as well as online monitoring systems in the production process. Data updates are frequent, especially during research and development and clinical trial stages, with new batch data and research results continuously generated. Document structures are highly standardized, generally following GMP/GLP guidelines. They contain substantial structured and semi-structured data, such as batch number, production date, expiration date, test item, test method, test result, unit, deviation description, and corrective actions. Fields often involve specific units and representations for nucleic acid sequence information, modification types, purity percentages, endotoxin content, and residual solvent concentrations.
Constraints Imposed by These Characteristics on "Workflow Orchestration"
The highly standardized and structured nature of siRNA nucleic acid drug quality documents demands high precision in data extraction and information comparison within workflow orchestration. For example, critical fields like batch number, sequence information, and purity must be accurately identified and extracted. Frequent data updates require workflows to have real-time or near real-time data ingestion capabilities, ensuring quality analysis and inspection readiness are based on the latest data. Specialized fields within documents, such as nucleic acid sequences and modification types, necessitate that the language models in the workflow possess professional biomedical domain knowledge to correctly understand and process this information, preventing misinterpretations. Furthermore, large volumes of historical batch data and stability study data place demands on the workflow's storage and retrieval performance, requiring efficient indexing and recall mechanisms. In inspection scenarios, workflows must support traceability to original data sources and generate audit trails compliant with regulatory requirements.
Configuration Guidelines
| Configuration Item | Suggested Value | Rationale for this Value |
|---|---|---|
File Type Whitelist | ['.pdf', '.docx', '.xlsx'] | Common formats for quality documents; ensures only relevant file types are processed |
Chunk size | 500–800 characters | Balances contextual completeness and model processing efficiency, suitable for dense technical paragraphs |
Recall count | 10 entries | Ensures coverage of critical information while avoiding interference from irrelevant data |
Similarity threshold | 0.75 | Higher than for general text, ensures recalled content is highly relevant to professional queries |
Model ID | gpt-4-turbo-2024-04-09 | Selects a model with strong reasoning and long context capabilities to handle complex quality analysis logic |
ParsingTimeout | 600 seconds | Allows sufficient parsing time for large batch production records or complex validation documents |
Three Common Pitfalls
- Workflow node connections cannot be created, leading to process interruption. This typically occurs when the output type of a preceding node does not match the input type of the subsequent node, or when required fields in the node configuration are incomplete or incorrect.
- Model call results within the workflow do not meet expectations, for example, incorrect batch number extraction or misidentification of purity units. This might be because the model has not been sufficiently fine-tuned for siRNA nucleic acid drug terminology and data formats, or the prompt design is not precise enough.
- Workflow debugging shows fast response times, but actual task conversations are noticeably slower, or even time out. This could be due to increased concurrency in the production environment, leading to high load on model services or databases, or the presence of unoptimized loops or recursive calls within the workflow.
How to Confirm Correct Configuration
- Select a document containing typical batch production records and test reports. Run the workflow and verify that key fields in the output, such as batch number, sequence, and purity, exactly match the original text.
- Simulate a deviation handling process. Input a document containing a deviation description and check if the workflow correctly identifies the deviation type and recommends appropriate corrective actions. Confirm the reasonableness of these actions with domain experts.
- Select multiple documents from different batches to test the workflow's concurrent processing capability. Observe whether node response times remain within acceptable limits under peak load and compare them against historical baseline data.
Note: The values provided are common starting points. It is crucial to measure and adjust them based on specific samples and requirements.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.